MiniMed Group, Inc.
MMEDNasdaq
$16.93
↑ +6.6%Jul 17 close · end-of-day
Price
1Y↓ -8.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.3B
Enterprise Value
$4.3B
P/E
—
P/S
1.4
P/B
1.3
EV/EBITDA
—
PEG
—
FCF Yield
-9.7%
Dividend Yield
—
Revenue (TTM)
$3.1B
Net Income (TTM)
-$333.0M
Free Cash Flow (TTM)
-$420.0M
Gross Margin
54.2%
Operating Margin
-6.1%
Net Margin
-10.7%
ROE
-9.6%
ROIC
-4.3%
Debt / Equity
—
Net Cash
$10.0M
Return 1Y
—
Company profile
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Our principal executive offices are located in Northridge, CA.
- CEO
- Que Dallara
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 8,000
- Headquarters
- California
- Website
- www.medtronicdiabetes.com
Management & directors
- Chandrasena GillianSVP, Chief HR Officer
- Dallara QueChief Executive Officer
- Dianaty AliSee Remarks
- Gyurci JohnVP, Chief Accounting Officer
- Spooner ChadEVP, Chief Financial Officer
- Wills Courtney NelsonSVP, Gen. Counsel, Corp. Sec.
Roles derived from SEC Form 4 filings.
Earnings
MMED Q3 2026 Earnings
Period ends 2026-01-23
MetricActualYoY
Revenue$790.0M↑ +15.0%
Diluted EPS-$0.47↑ +1075.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue | $2.5B | $2.7B | $3.1B |
| Gross profit | $1.4B | $1.5B | $1.7B |
| Operating income | -$69.0M | -$146.0M | -$190.0M |
| Net income | -$112.0M | -$213.0M | -$333.0M |
| Diluted EPS | -$0.44 | -$0.84 | -$1.30 |
| Operating cash flow | $41.0M | $140.0M | -$197.0M |
| Free cash flow | -$107.0M | -$53.0M | -$420.0M |
| Gross margin | 58.2% | 56.3% | 54.2% |
| Operating margin | -2.8% | -5.4% | -6.1% |
| Net margin | -4.5% | -7.8% | -10.7% |
| Line item | Q3 '25 | Q3 '26 |
|---|---|---|
| Revenue | $687.0M | $790.0M |
| Gross profit | $395.0M | $362.0M |
| Operating income | $21.0M | -$100.0M |
| Net income | -$10.0M | -$119.0M |
| Diluted EPS | -$0.04 | -$0.47 |
| Operating cash flow | — | — |
| Free cash flow | — | — |
| Gross margin | 57.5% | 45.8% |
| Operating margin | 3.1% | -12.7% |
| Net margin | -1.5% | -15.1% |
Company news
Jul 20, 2026
Jun 17, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Wills Courtney Nelson· SVP, Gen. Counsel, Corp. Sec. | Award | 60,730 | $0.00 | $0.00 | filing |
| 2026-07-01 | Wills Courtney Nelson· SVP, Gen. Counsel, Corp. Sec. | Award | 22,057 | $0.00 | $0.00 | filing |
| 2026-07-01 | Gyurci John· VP, Chief Accounting Officer | Award | 24,244 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chandrasena Gillian· SVP, Chief HR Officer | Award | 29,483 | $0.00 | $0.00 | filing |
| 2026-07-01 | Chandrasena Gillian· SVP, Chief HR Officer | Award | 14,705 | $0.00 | $0.00 | filing |
| 2026-07-01 | Spooner Chad· EVP, Chief Financial Officer | Award | 94,550 | $0.00 | $0.00 | filing |
| 2026-07-01 | Spooner Chad· EVP, Chief Financial Officer | Award | 22,057 | $0.00 | $0.00 | filing |
| 2026-07-01 | Dianaty Ali· See Remarks | Award | 94,550 | $0.00 | $0.00 | filing |
| 2026-07-01 | Dianaty Ali· See Remarks | Award | 36,762 | $0.00 | $0.00 | filing |
| 2026-07-01 | Dallara Que· Chief Executive Officer | Award | 297,618 | $0.00 | $0.00 | filing |
| 2026-03-25 | Dallara Que· Chief Executive Officer | Tax withholding | 4,809 | $16.31 | $78,434.79 | filing |
| 2026-03-11 | Gyurci John· See Remarks | Award | 15,322 | — | — | filing |
| 2026-03-11 | Chandrasena Gillian· See Remarks | Award | 19,852 | — | — | filing |
| 2026-03-11 | Chandrasena Gillian· See Remarks | Award | 28,116 | — | — | filing |
| 2026-03-11 | Chandrasena Gillian· See Remarks | Award | 58,825 | — | — | filing |
| 2026-03-11 | Chandrasena Gillian· See Remarks | Award | 11,486 | — | — | filing |
| 2026-03-11 | Chandrasena Gillian· See Remarks | Award | 11,486 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 18,082 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 955 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 11,486 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 5,151 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 13,646 | — | — | filing |
| 2026-03-11 | Wills Courtney Nelson· See Remarks | Award | 5,743 | — | — | filing |
| 2026-03-11 | Dianaty Ali· See Remarks | Award | 11,054 | — | — | filing |
| 2026-03-11 | Dianaty Ali· See Remarks | Award | 46,989 | — | — | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.